Italy long-acting bronchodilator market is anticipated to grow at a substantial rate of 2.5% during the forecast period. The significant prevalence of asthma and COPD has augmented the demand for long-acting bronchodilators within the country. Moreover, rising tobacco smoking activities in the country have also led to the various respiratory disease that has addressed the need for respiratory devices, such as bronchodilators, in the country. In addition, the presence of market players such as Chiesi Farmaceutici S.P.A. in the country is also propelling the market growth. In September 2017, the company completed the clinical study of Tribute with its Trimbow an extra-fine fixed-dose triple combination inhaler. Upon successful commercialization of this long-acting bronchodilator in the country in the near future, the market for the respiratory device such as long-acting bronchodilators will grow.
To Request a Sample of our Report on Italy Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/italy-long-acting-bronchodilator-market
Italy long-acting bronchodilator market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, nasal, parenteral, and inhalation. The oral route of administration segment is estimated to contribute to the significant market share in the Italian market over the forecast period. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the country.
(Get 15% Discount on Buying this Report)
A full Report of Italy Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/italy-long-acting-bronchodilator-market
Italy Long-Acting Bronchodilator Market Segmentation
By Route of Administration
- Oral
- Nasal
- Parenteral
- Inhalation
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By End-User
- Homecare
- Hospitals and Clinics
Company Profiles
- Adamis Pharmaceuticals Corp.
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Novartis AG
- ResMed Corp.
- Pulmatrix Inc.
- Savara, Inc.
- Sunovion Pharmaceuticals
- Teva Pharmaceuticals Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
